浙江诚意药业股份有限公司 关于控股股东及其一致行动人权益变动触及1%刻度的提示性公告

Group 1 - The core viewpoint of the announcement is that the major shareholders of Zhejiang Chengyi Pharmaceutical Co., Ltd. have reduced their holdings, which does not trigger a mandatory bid or affect the company's control structure [1][2]. - As of the announcement date, shareholder Yan Xiaoling has reduced her holdings by 349,722 shares, while Wenzhou Dongtou Chengyi Microfinance Co., Ltd. has reduced its holdings by 2,164,900 shares, totaling a reduction of 2,514,622 shares, which accounts for 0.77% of the company's total share capital [1]. - Following this reduction, the combined shareholding of controlling shareholder Yan Yiyi and his concerted actions decreased from 81,067,702 shares to 78,553,080 shares, resulting in a shareholding ratio drop from 24.77% to 24.00% [1]. Group 2 - The reduction in holdings is part of a previously disclosed plan and does not involve any changes to the company's governance structure or operational continuity [2]. - The reduction aligns with the commitments made by the information disclosure obligors and does not harm the interests of the company or its shareholders [2]. - The reduction plan has not yet been fully implemented as of the announcement date [2].